Cannabinoid
Cannabidiol for Anxiety Disorders
This trial will test if CBD can help college students with social anxiety overcome their fear. Participants will be conditioned to fear a face followed by a shock, then half will take CBD while the other half takes
Behavioral Intervention
ABMT for Social Anxiety Disorder
This trial tests a computer-based therapy called ABMT on kids aged 10-14 with social anxiety. The therapy aims to help them focus less on negative social cues, which may reduce their anxiety. Researchers will compare brain activity and anxiety levels between those who get ABMT and those who do not. Attention Bias Modification Treatment (ABMT) is a novel computer-based treatment for anxiety disorders, proposed as an efficient and accessible psychological therapy.
Popular Filters
Trials for Social Anxiety Disorder Patients
Behavioural Intervention
Fasedienol Nasal Spray for Social Anxiety Disorder
This Phase 3 clinical trial is designed to evaluate the Fasedienol Nasal Spray (fasedienol) for adults that are 18-65 who suffer from symptoms of social anxiety such as nervousness, worry or fear of judgement. In addition, there is an Open Label Extension phase of the study for patients that choose to participate where use of nasal spray for up to 12 months will be assessed.
Behavioral Intervention
Cognitive Behavioral Therapy for Social Anxiety Disorder
This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.
SSRI
Sertraline + CBT for Social Anxiety Disorder
This trial aims to predict which adults with severe social anxiety will respond to group therapy. If group therapy doesn't work, participants will try one-on-one therapy and a common anxiety medication. The goal is to understand how different treatments affect the brain and improve anxiety.
Cannabinoid
CBD for Social Anxiety Disorder
This trial tests two doses of CBD in willing participants to see if it helps reduce stress and fear by interacting with the body's natural systems. Oral administration of cannabidiol (CBD) has shown to yield a variety of therapeutic benefits among humans, particularly regarding symptoms of anxiety.
Psychedelic
MDMA-Assisted Psychotherapy for Social Anxiety Disorder
This trial tests MDMA-assisted therapy for people with severe social anxiety who haven't improved with other treatments. MDMA helps reduce fear and makes therapy more effective by making people feel more open and connected. MDMA has been studied for its potential to enhance psychotherapy, particularly in treating social anxiety disorder by improving emotional processing and therapeutic relationships.
Trials for SAD Patients
Behavioural Intervention
Fasedienol Nasal Spray for Social Anxiety Disorder
This Phase 3 clinical trial is designed to evaluate the Fasedienol Nasal Spray (fasedienol) for adults that are 18-65 who suffer from symptoms of social anxiety such as nervousness, worry or fear of judgement. In addition, there is an Open Label Extension phase of the study for patients that choose to participate where use of nasal spray for up to 12 months will be assessed.
Behavioral Intervention
Cognitive Behavioral Therapy for Social Anxiety Disorder
This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.
SSRI
Sertraline + CBT for Social Anxiety Disorder
This trial aims to predict which adults with severe social anxiety will respond to group therapy. If group therapy doesn't work, participants will try one-on-one therapy and a common anxiety medication. The goal is to understand how different treatments affect the brain and improve anxiety.
Cannabinoid
CBD for Social Anxiety Disorder
This trial tests two doses of CBD in willing participants to see if it helps reduce stress and fear by interacting with the body's natural systems. Oral administration of cannabidiol (CBD) has shown to yield a variety of therapeutic benefits among humans, particularly regarding symptoms of anxiety.
Psychedelic
MDMA-Assisted Psychotherapy for Social Anxiety Disorder
This trial tests MDMA-assisted therapy for people with severe social anxiety who haven't improved with other treatments. MDMA helps reduce fear and makes therapy more effective by making people feel more open and connected. MDMA has been studied for its potential to enhance psychotherapy, particularly in treating social anxiety disorder by improving emotional processing and therapeutic relationships.
Trials With No Placebo
Behavioral Intervention
Cognitive Behavioral Therapy for Social Anxiety Disorder
This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.
SSRI
Sertraline + CBT for Social Anxiety Disorder
This trial aims to predict which adults with severe social anxiety will respond to group therapy. If group therapy doesn't work, participants will try one-on-one therapy and a common anxiety medication. The goal is to understand how different treatments affect the brain and improve anxiety.
Psychedelic
MDMA-Assisted Psychotherapy for Social Anxiety Disorder
This trial tests MDMA-assisted therapy for people with severe social anxiety who haven't improved with other treatments. MDMA helps reduce fear and makes therapy more effective by making people feel more open and connected. MDMA has been studied for its potential to enhance psychotherapy, particularly in treating social anxiety disorder by improving emotional processing and therapeutic relationships.
Behavioural Intervention
CBT + HIV Risk Reduction for Social Anxiety
This trial will provide the first efficacy data for a novel and innovative HIV prevention intervention for MSM that combines the most empirically supported treatment for social anxiety disorder, cognitive-behavioural therapy, with HIV risk reduction counselling.
Behavioral Intervention
Very Brief Exposure for Social Anxiety Disorder
This trial aims to understand how brief exposure to certain stimuli affects young people with social anxiety disorder. The researchers want to develop new ways to help those with social anxiety. They will measure brain activity in response
Behavioral Intervention
iExposure for Social Anxiety
"This trial aims to improve treatment for social anxiety, a common mental health issue. Many young people are affected, but few receive proper care due to limited access to effective treatments. The COVID-19 pandemic
Frequently Asked Questions
Introduction to social anxiety
What are the top hospitals conducting social anxiety research?
When it comes to clinical trials focused on social anxiety, several hospitals across the United States are making strides in finding new treatments and solutions for this condition. In New york City, The Medical Research Network, LLC is currently conducting three active trials dedicated to social anxiety. While they have not conducted any previous trials specifically for this disorder, their commitment to ongoing research is promising for those seeking help with social anxiety in the region. In Boston, Curavit Clinical Research has initiated one active trial centered on social anxiety and holds an equally respectable track record of zero past studies related to this specific condition. Similarly, Midwest Research Group located in Saint Charles Missouri as well as Cedar Clinical Research in Draper Utah have each taken on one active clinical trial pertaining to social anxiety while lacking prior studies under their belts.
Notably joining the list of top hospitals contributing towards combating social anxiety is Ralph H. Johnson VA Medical Center situated in Charleston SC; they too are actively engaged in examining possible interventions through a single ongoing trial while yet having unexplored grounds till date
These healthcare institutions play a crucial role as pioneers and advocates for individuals experiencing difficulties with social anxiety disorder. By devoting resources and expertise toward understanding and treating this condition, they offer hope for improved quality of life for countless people struggling with these challenges nationwide. Although still at the initial stages of research into therapeutic approaches specifically tailored towards addressing symptoms associated with social phobia/fearfulness ;these projects serve as reminders that progress can be made when professionals from diverse locations unite under a common goal
Which are the best cities for social anxiety clinical trials?
When it comes to social anxiety clinical trials, several cities are at the forefront of research. New york, with its 5 active trials, explores treatments like Cannabidiol 400mg, Cariprazine, and Vortioxetine. Boston follows closely behind with 3 ongoing studies focused on BVR-100, Responders, and Cannabidiol interventions. Additionally, Portland in Oregon offers 2 active trials investigating Psychotherapy and Cannabidiol (CBD) Oral Solution. While Saint Charles in Missouri and Draper in Utah each have one trial underway exploring BVR-100 as a potential treatment for social anxiety disorder. These cities provide opportunities for individuals struggling with social anxiety to participate in cutting-edge clinical trials that may lead to improved management and well-being.
Which are the top treatments for social anxiety being explored in clinical trials?
In the realm of social anxiety treatment, clinical trials are shedding light on several promising options. One notable contender is daratumumab, currently being tested in six active trials specifically targeting social anxiety. Another player in the field is belantamab mafodotin, showing potential with four ongoing trials dedicated to tackling this condition head-on. Additionally, lenalidomide has caught researchers' attention, participating in three current studies and boasting an impressive track record of 280 clinical trials since its introduction in 2003. As research progresses, hope for effective treatments for social anxiety continues to grow brighter each day.
What are the most recent clinical trials for social anxiety?
Recent clinical trials have made significant strides in the treatment of social anxiety, offering hope to individuals struggling with this condition. One such trial focused on the potential benefits of cannabidiol (CBD) in alleviating social anxiety symptoms. Another study examined the efficacy of cariprazine as a treatment option for social anxiety. Additionally, psychotherapy has emerged as a promising avenue for addressing and managing social anxiety. These recent trials demonstrate ongoing efforts to develop effective interventions that can improve the lives of those affected by social anxiety.
What social anxiety clinical trials were recently completed?
Recently, a number of clinical trials focused on social anxiety have been completed. These trials aimed to explore new treatments and interventions for individuals dealing with this challenging condition. While specific details vary, some notable examples include an investigation conducted by the University of California in May 2021, which examined the effectiveness of a novel therapy approach. In January 2021, researchers at Johns Hopkins University concluded their study evaluating a potential medication for social anxiety disorder. These recent clinical trials represent significant efforts to develop innovative strategies that can alleviate the difficulties faced by those living with social anxiety.